Jesse Engreitz, PhD
Previously, Jesse was a Junior Fellow at the Harvard Society of Fellows and led a research group at the Broad Institute of MIT and Harvard. During his postdoctoral fellowship at the Broad Institute, Jesse developed large-scale CRISPR tools to map enhancer-gene regulation with Eric Lander and Nir Hacohen, and launched the Variants-to-Function (V2F) Initiative to connect genetic disease variants to their molecular and cellular functions. Jesse previously attended Stanford University, where he developed computational algorithms for analyzing gene expression with Russ Altman, and completed his PhD in the Harvard-MIT Division of Health Sciences and Technology, where he studied genome regulation by long noncoding RNAs with Eric Lander and Mitch Guttman. His research has been supported by the National Human Genome Research Institute, Foundations for the National Institutes of Health, Harvard Society of Fellows, Fannie and John Hertz Foundation, and Department of Defense. Outside the lab, Jesse enjoys playing jazz/rock/funk, testing Chinese recipes, and surfing.
Casey Gifford, PhD
Casey is currently an Assistant Professor in the Department of Pediatrics and, by courtesy, of Genetics. Prior to joining Stanford, she was an HHMI fellow of the Damon Runyon Cancer Research Foundation at the Gladstone Institutes and UCSF in the lab of Deepak Srivastava, M.D. While at the Gladstone Institutes, she employed recent advances in gene editing and gene expression technologies to study cardiovascular development and disease. She earned her B.S. in Biochemistry from Simmons University and her Ph.D. from Harvard University and the Broad Institute where she studied the epigenomic mechanisms that underlie pluripotent stem cell differentiation in the lab of Alex Meissner. Research in her lab is focused on defining the complex genetic and molecular mechanisms associated with congenital heart disease using both rodent and stem cell experimental models. Ultimately, she hopes to make personalized medicine a reality for those that suffer from cardiovascular anomalies.
Mark Skylar-Scott, PhD
Mark joined Stanford Unversity's Bioengineering Department in July 2020. Previously, he was a research fellow in Jennifer Lewis' group in the John A. Paulson School of Engineering & Applied Sciences as well as the Wyss Institute for Biologically Inspired Engineering at Harvard University. He obtained his B.A. and M.Eng. degrees from Cambridge University, and his Ph.D. in Medical and Electrical Engineering from the Department of Health Science & Technology at the Massachusetts Institute of Technology, focusing on high-resolution multiphoton microfabrication of capillary networks.
Mark's research focuses on cardiovascular tissue biomanufacturing, seeking to push the complexity and scale at which tissue can be designed and manufactured on demand. By integrating high-throughput culture of designer organoids with new machines and methods for advanced 3D bioprinting, his laboratory seeks to enhance the maturation and function of vascularized cardiac tissues in vitro and in vivo.